Stephen Connelly, Chief Scientific Officer at Equillium, Inc. (EQ), sold 8,092 shares at $7.01 ($57K) on 2021-10-06, disclosed to the SEC on 2021-10-07.
Scheduled sale ($57k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.01 | 2,467 | $17K | 30.5% |
| 2 | $7.01 | 5,625 | $39K | 69.5% |
| Total | $7.01 avg | 8,092 | $57K | 100% |
| Filing → |
| EQ | SELL | 2020-12-30 | $226K | — | Filing → |
| EQ | SELL | 2020-09-30 | $141K | — | Filing → |
| EQ | SELL | 2020-07-15 | $4.1M | — | Filing → |